Cervical Cancer Screening: Role of Genomics

Genomics|Update|Current

Cervical Cancer Screening: Role of Genomics

The US Food and Drug Administration approves 1st human papillomavirus DNA test for primary cervical cancer screening (April 24, 2014)

Alternative to Pap Test Is Approved by F.D.A.,  by Andrew Pollack, New York Times, Apr 24

Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study. 
Zorzi M et al. BJOG (2013)

CDC information: Cervical cancer is the easiest female cancer to prevent, with regular screening tests and follow-up

FDA approves genetic test as first U.S. alternative to Pap smear, by Matthew Perrone, Washington Post, Apr 24

FDA approves HPV test as initial screen for cervical cancer, Medline Plus, Apr 24